Table 2.

Samples Included in Current Analysis

Treatment Groupa	Treatment Responders, No.		Samples, No.
	Total	Included in Analysis	Baseline	10 d	30 d	60 d	RBX2660b
A	25	22	18	18	17	13	44
B	19	15	13	11	10	12
C	25	21	18	17	13	18	21

^aGroup A received 2 doses of RBX2660; group B, 2 doses of placebo; and group C, 1 dose of RBX2660 followed by 1 dose of placebo.

^bDenotes RBX2660 dose samples included in sequencing analyses.